Nobel winner signs deal
Source: Xinhua |
November 4, 2012, Sunday
|
Print Edition
Print Edition
NOBEL laureate Martin Evans yesterday signed an agreement on conducting stem cell anti-aging research with Zhongyuan Union Stem Cell Bio-engineering Corporation in north China's Tianjin Municipality.
Evans was awarded the Nobel Prize in Physiology or Medicine in 2007 and co-established Cell Therapy Ltd (CTL), a biological high-tech enterprise undertaking stem cell research and clinical application, in Wales.
Under the agreement, domestic life science and technology enterprise Zhongyuan and CTL will jointly invest US$8 million to create a new company this year in Tianjin. This will industrialize achievements from research.
The prospects for anti-aging research on stem cells are "brilliant," said Evans.
Evans was awarded the Nobel Prize in Physiology or Medicine in 2007 and co-established Cell Therapy Ltd (CTL), a biological high-tech enterprise undertaking stem cell research and clinical application, in Wales.
Under the agreement, domestic life science and technology enterprise Zhongyuan and CTL will jointly invest US$8 million to create a new company this year in Tianjin. This will industrialize achievements from research.
The prospects for anti-aging research on stem cells are "brilliant," said Evans.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
